A recent case report about a man who received an mRNA-based COVID-19 vaccine suggests that taking the vaccine “may trigger immune-mediated hepatitis,” researchers wrote.
The natural immunity provided by COVID-19 infection in unvaccinated adults is on par with protection conferred from vaccines against reinfection with or hospitalization from the virus, a new study reveals.
Judicial Watch today announced it received 466 pages of records from the U.S. Department of Health and Human Services (HHS) regarding biodistribution studies and related data for the COVID-19 vaccines that show a key component of the vaccines developed by Pfizer/BioNTech, lipid nanoparticles (LNPs), were found outside the injection site, mainly the liver, adrenal glands, spleen and ovaries of test animals, eight to 48 hours after injection.
Since the beginning of 2021, the official narrative with regards to the COVID-19 vaccines has maintained that they are safe, efficacious, and working well. For example, Premier Mark McGowan of Western Australia confidently stated that “by getting to higher levels of third dose vaccination we’re going to save lots of lives.”
Pfizer on Tuesday said results of Phase 2 clinical trials of its experimental Lyme disease vaccine delivered “positive” results, including among pediatric trial participants.